Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Exchange Rate Effect (2016 - 2024)

Rockwell Medical (RMTI) has disclosed Exchange Rate Effect for 5 consecutive years, with -$1000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Exchange Rate Effect fell 200.0% year-over-year to -$1000.0, compared with a TTM value of -$5000.0 through Sep 2025, down 66.67%, and an annual FY2024 reading of -$5000.0, down 25.0% over the prior year.
  • Exchange Rate Effect was -$1000.0 for Q4 2024 at Rockwell Medical, roughly flat from -$1000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1000.0 in Q4 2023 and bottomed at -$3000.0 in Q1 2023.
  • Average Exchange Rate Effect over 3 years is -$1333.3, with a median of -$1000.0 recorded in 2022.
  • Peak annual rise in Exchange Rate Effect hit 50.0% in 2023, while the deepest fall reached 200.0% in 2023.
  • Year by year, Exchange Rate Effect stood at -$2000.0 in 2022, then surged by 150.0% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for RMTI at -$1000.0 in Q4 2024, -$1000.0 in Q3 2024, and -$3000.0 in Q2 2024.